AMGN vs JNJ: Side-by-Side Comparison
Compare AMGEN Inc (AMGN) and Johnson & Johnson (JNJ) side by side: market cap USD 201.93B vs USD 633.19B, P/E 26.0 vs 30.4. Financials, growth and model signals on Bullrun.
| Metric | AMGN | JNJ |
|---|---|---|
| Company | AMGEN Inc | Johnson & Johnson |
| Country / Exchange | United States · NASDAQ | United States · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-General | Drug Manufacturers-General |
| Market cap | USD 201.93B | USD 633.19B |
| P/E ratio | 26.0 | 30.4 |
| Dividend yield | 2.62% | 1.99% |
| Valuation model | 4.2% undervalued | 3.0% undervalued |
| Revenue (FY2025) | USD 36.75B | USD 94.19B |
| Revenue growth YoY | +10.0% | +6.0% |
| Net income | USD 7.71B | USD 26.80B |
| Gross margin | 67.2% | 67.9% |
| Diluted EPS | 14.23 | 11.03 |